Tang Capital Management’s GSK GSK Stock Holding History

Tang Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,000	Closed	-$14.7M	–	59
2025 Q4	$14.7M	Sell	300,000 -100,000	-25%	-$4.66M	0.73%	31
2025 Q3	$17.3M	Hold	400,000	–	–	0.66%	40
2025 Q2	$15.4M	Hold	400,000	–	–	0.78%	37
2025 Q1	$15.5M	Hold	400,000	–	–	0.86%	32
2024 Q4	$13.5M	Sell	400,000 -50,000	-11%	-$1.8M	0.9%	29
2024 Q3	$18.4M	Buy	450,000 +50,000	+13%	+$2.05M	1.31%	20
2024 Q2	$15.4M	Buy	400,000 +100,000	+33%	+$4.21M	1.57%	20
2024 Q1	$12.9M	Hold	300,000	–	–	1.34%	24
2023 Q4	$11.1M	Buy	+300,000	New	+$10.8M	1.03%	27

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tang Capital Management's GSK Position: Q1 2026 in Review

Tang Capital Management sold out of GSK (GSK) in Q1 2026, closing a stake of 300,000 shares — an estimated $14.7M sold.

Tang Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters. The position peaked at $18.4M in Q3 2024. 1,036 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Tang Capital Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Tang Capital Management sold 300,000 GSK shares in Q1 2026, an estimated $14.7M.
Tang Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters.
Tang Capital Management's GSK position peaked at $18.4M in Q3 2024.
1,036 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.